ROBERT I TEPPER Insider Trading $JNCE Jounce Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ROBERT I TEPPER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ROBERT I TEPPER. ROBERT I TEPPER is President, R&D in MILLENNIUM PHARMACEUTICALS INC ($MLNM) and Director in CONSTELLATION PHARMACEUTICALS INC ($CNST) and Director in Kala Pharmaceuticals, Inc. ($KALA) and 10% Owner in CytomX Therapeutics, Inc. ($CTMX) and Director in Allena Pharmaceuticals, Inc. ($ALNA) and 10% Owner in Global Blood Therapeutics, Inc. ($GBT) and Director in Jounce Therapeutics, Inc. ($JNCE) and Director in Neon Therapeutics, Inc. ($NTGN).
ROBERT I TEPPER in Jounce Therapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of ROBERT I TEPPER: Director
Holdings: 10,230,349 shares
Current Value: $176,985,038
Latest Transaction: Jun 29 2020
$JNCE Market Capitalization: $140.99M
$JNCE Previous Close: $17.30
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of ROBERT I TEPPER in Jounce Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALNA, CNST, CTMX, GBT, JNCE, KALA, MLNM, NTGN
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 29 2020 | JNCE | Jounce Therapeutic ... | TEPPER ROBERT I | Director | Option Exercise | A | 7.58 | 13,550 | 102,709 | 13,550 | |
| Jun 13 2019 | JNCE | Jounce Therapeutic ... | TEPPER ROBERT I | Director | Option Exercise | A | 4.46 | 15,700 | 70,022 | 15,700 | |
| Jun 21 2018 | JNCE | Jounce Therapeutic ... | TEPPER ROBERT I | Director | Option Exercise | A | 7.92 | 13,550 | 107,316 | 13,550 | |
| Feb 03 2017 | JNCE | Jounce Therapeutic ... | TEPPER ROBERT I | Director | Option Exercise | C | 0.00 | 11,250,000 | 0 | 0 | |
| Feb 03 2017 | JNCE | Jounce Therapeutic ... | TEPPER ROBERT I | Director | Option Exercise | C | 0.00 | 35,750,000 | 0 | 0 | |
| Feb 03 2017 | JNCE | Jounce Therapeutic ... | TEPPER ROBERT I | Director | Buy | C | 0.00 | 3,048,780 | 0 | 3,048,780 | 0 to 3 M |
| Feb 03 2017 | JNCE | Jounce Therapeutic ... | TEPPER ROBERT I | Director | Buy | C | 0.00 | 9,688,344 | 0 | 10,230,349 | 542 K to 10.2 M (+1,787.50 %) |
Page: 1